Medscape |
Glaucoma Drug Eyed as Novel Diabetes Treatment 'Archetype'
Medscape An old glaucoma drug could present a new avenue for treating type 2 diabetes and related conditions, a proof-of-concept study suggests. Methazolamide, a carbonic-anhydrase (CA) inhibitor approved by the US Food and Drug Administration in 1959, … and more » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.